General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine
(2000; 80 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAcknowledgements
Ver el documentoForeword
Abrir esta carpeta y ver su contenidoIntroduction
Abrir esta carpeta y ver su contenido1. Methodologies for Research and Evaluation of Herbal Medicines
Abrir esta carpeta y ver su contenido2. Methodologies for Research and Evaluation of Traditional Procedure-Based Therapies
Abrir esta carpeta y ver su contenido3. Clinical Research
Abrir esta carpeta y ver su contenido4. Other Issues and Considerations
Ver el documentoReferences
Abrir esta carpeta y ver su contenidoAnnexes
Abrir esta carpeta y ver su contenidoAnnex I. Guidelines for the Assessment of Herbal Medicinesa
Abrir esta carpeta y ver su contenidoAnnex II. Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicinesa
Cerrar esta carpetaAnnex III. Report of a WHO Consultation on Traditional Medicine and AIDS: Clinical Evaluation of Traditional Medicines and Natural Productsa
Ver el documentoPreclinical Considerations
Ver el documentoClinical Considerations
Ver el documentoRecommendations
Abrir esta carpeta y ver su contenidoAnnex IV. Definition of Levels of Evidence and Grading of Recommendationa
Abrir esta carpeta y ver su contenidoAnnex V. Guidelines for Levels and Kinds of Evidence to Support Claims for Therapeutic Goodsa
Abrir esta carpeta y ver su contenidoAnnex VI. Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Productsa
Abrir esta carpeta y ver su contenidoAnnex VII. Guidance for Industry: Significant Scientific Agreement in the Review of Health Claims for Conventional Foods and Dietary Supplementsa
Abrir esta carpeta y ver su contenidoAnnex VIII. Guideline for Good Clinical Practicea
Abrir esta carpeta y ver su contenidoAnnex IX. WHO QOL (Quality of Life) User Manual: Facet Definitions and Response Scalesa
Ver el documentoAnnex X. Participants in the WHO Consultation on Methodologies for Research and Evaluation of Traditional Medicine
 

Recommendations

A place for traditional herbal remedies in the health care system will be established only if recommendations for their use are based on studies that make them credible and acceptable. Thus, studies with herbal medicines must satisfy the same criteria of efficacy and safety as do the drugs that are products of the modern pharmaceutical industry.

In this context, the consultation drew up a series of guidelines for clinical trials with traditional medicine products used in the treatment of AIDS and AIDS-related diseases.

The consultation also made the following recommendations:

1. This report should be given wide distribution so that the guidelines can be readily and immediately applied in countries where potential remedies may exist.

2. The guidelines should be used as the basis for the development of clinical trials for the evaluation of traditional medicines and natural products.

3. WHO should monitor the impact of the use of the guidelines at the country level to determine any needs for revision.

4. A second consultation should be convened in two years’ time to revise the guidelines on the basis of experience in their use.

5. The WHO Traditional Medicine Programme, together with the WHO Global Programme on AIDS, should jointly identify appropriate institutions in developing countries where clinical evaluation of traditional medicines and natural products for AIDS could be carried out.

6. Other consultations should be convened by the WHO Traditional Medicine Programme, in collaboration with appropriate WHO programmes, to adapt the guidelines for the clinical evaluation of traditional medicines for other primary disease states that are of concern in developing countries, such as malaria and other parasitic diseases.

 

Ir a la sección anterior
Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019